Page 3 - வெளியிடப்பட்டது பிப்ரவரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article MY01 provides the necessary immediate and timely information (1) to aid physicians in monitoring patients at-risk of developing Compartment Syndrome.(2)   MONTREAL, May 6, 2021 /PRNewswire/ - MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions, improving patient outcomes. MY01 inc. today announced U.S. Food and Drug Administration 510(k) clearance for the MY01 Continuous Compartment Pressure Monitor with full Bluetooth capabilities. MY01 s Continuous Compartment Pressure Monitor uses a proprietary and innovative technology to deliver a highly reliable, accurate continuous pressure microsensor directly within the muscle.(2) The  is a sterile, single-use device. The easy-to-use nature of the MY01 device allows organizations to allocate their healthcare resources to focus on more important activities. Only the MY01 device provides quick, reliable and continuous pressure

United statesTed harveyDrug administrationAmerican academy of orthopaedic surgeonsCompartment syndromeCompartment pressure monitorCompartmental pressure monitorAcute compartment syndromeAmerican academyOrthopaedic surgeonsNorth americaEstimated sensitivityCompartment pressure monitoringAcute compartmentThree devicesMeasure pressure